Status:
UNKNOWN
Macular Hole Surgery With Temporal Inverted Internal Limiting Membrane Flap (MARTIAL)
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Macula Hole
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Since 1991, idiopathic macular holes (MH) can benefit from an effective treatment initially involving pars plana vitrectomy, stripping of epiretinal membranes and intraocular gas tamponade followed by...
Eligibility Criteria
Inclusion
- Patients older than 18 years old
Exclusion
- Underage patients
- History of intraocular surgery (except for cataract surgery)
- Macular hole secondary to trauma, diabetic retinopathy, uveitis or associated with retinal detachment
- Concurrent macular disease (diabetic maculopathy, age-related macular degeneration)
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT03287102
Start Date
February 1 2018
End Date
February 1 2020
Last Update
January 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brabois Hospital
Vandœuvre-lès-Nancy, France, 54500